[1] DOSER K, NORUP A. Caregiver burden in Danish family members of patients with severe brain injury: The chronic phase[J]. Brain Inj,2016,30(3):334-42. [2] 姚海军,胡锦,袁强,等.3144例重型颅脑损伤住院患者临床特点分析[J].山东医药,2015,55(30):67-69. [3] 周俊杰,田丹,黄文涛,等.亚低温治疗对重型颅脑损伤患者的血清S100B蛋白的影响及其脑保护作用[J].广州医学院学报,2013,41(6):34-36. [4] 赵卫海,海陈炼,余国栋,等.血清TNF-α IL-1 IL-6 IL-8在急性颅脑损伤后含量变化及意义[J].中国实用神经疾病杂志,2013,16(16):22-23. [5] TIAN Y, DU HG, FAN CP, et al. Clinical significance of percutaneous endoscopic gastrostomy for patients with severe craniocerebral injury[J]. Chin J Traumatol,2014,17(6):341-344. [6] 赵龙,刘泉,林岚,等.标准大骨瓣减压术对重型颅脑损伤患者脑血流动力学及代谢状态的影响[J].实用临床医药杂志,2016,20(19):83-85. [7] NAYEBAGHAYEE H, AFSHARIAN T. Correlation between Glasgow Coma Scale and brain computed tomography-scan findings in head trauma patients[J]. Asian J Neurosurg,2016,11(1):46-9. [8] JAVED G, KHAN MB, AHMED SI, et al. Dhaga Technique for Tissue Plane Preservation after Decompressive Craniectomy: Comparison of New Technique with Institutional Standard[J]. World Neurosurg,2015 ,84(3):709-13. [9] 孙立,贾振锋,郭金光,等.重型颅脑损伤患者单侧去骨瓣减压术后挫伤性脑出血增大的相关因素及与预后的关系[J].实用临床医药杂志,2015,19(13):85-87. [10]吴光辉,高如生,刘明,等.急性颅脑损伤患者血清NSE和S-100B水平的变化及临床意义[J].中国伤残医学,2014,22(1):24-26. [11]刘海鹏,单小松,郑克彬,等.高压氧治疗重型颅脑损伤的疗效及对血清IL-1β和IL-6的影响[J].中国实用神经疾病杂志,2014,17(11):52-53. [12]汪义发,汪毓君.老年重症颅脑损伤并发肺部感染后PCT、CRP等炎性标记物变化[J].陕西医学杂志,2016,45(1):97-99. [13]AIVIS-MIRANDA HR, CASTELLSR-LEONES SM, MOSCOTE-SALAZAR LR. Intravenous Fluid Therapy in Traumatic Brain Injury and Decompressive Craniectomy[J]. Bull Emerg Trauma,2014,2(1):3-14. [14]陈茂送,王洪财,严斌,等.标准大骨瓣减压术对重型颅脑损伤患者颅内压及预后的影响[J].中国现代医生,2014,52(1):16-19. [15]吕建华,张洪兵,王刚,等.去骨瓣减压术后早期颅骨成形术对重型颅脑损伤患者神经功能恢复及预后的改善作用[J].山东医药,2015,55(15):84-85. [16]师镜峰.单唾液酸四己糖神经节苷脂联合依达拉奉对急性颅脑损伤患者脑保护作用的临床观察[J].医学临床研究,2015,32(10):2017-2020. [17]周路球,马真,纠智松,等.轻度低温联合依达拉奉治疗提高重型颅脑损伤疗效[J].中华神经医学杂志,2013,12(8):815-818. [18]李凯,周杰,车万民,等.依达拉奉对中、重型颅脑损伤患者脑水肿及预后的影响[J].实用临床医药杂志,2014,18(16):128-130.
